

Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.
You can purchase shares of ARK Genomic Revolution ETF (BATS:ARKG) through any online brokerage.
There are no as such competitors for ARK Genomic Revolution ETF.
There is no analysis for ARK Genomic Revolution ETF to provide a consensus price target.
The stock price for ARK Genomic Revolution ETF (BATS: ARKG) is $ last updated .
There are no upcoming dividends for ARK Genomic Revolution ETF.
ARK Genomic Revolution ETF does not have any upcoming earnings scheduled.
There is no upcoming split for ARK Genomic Revolution ETF.
The Fund is an actively managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80 percent of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare,...